Bacil Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/07/2026 inter alia to consider and approve 1. The proposal for raising funds by way of a Rights Issue of equity shares to the eligible equity shareholders of the Company for an aggregate amount of up to ?50 00 00 000 (Rupees Fifty Crores Only) in accordance with the applicable provisions of the Companies Act 2013 the SEBI (Issue of Capital and Disclosure Requirements) Regulations 2018 the SEBI (LODR) Regulations 2015 and other applicable laws.2. The proposal for increase in the Authorised Share Capital of the Company.3. Consequent alteration of the Capital Clause of the Memorandum of Association of the Company. 4. To determine and approve the detailed terms and conditions of the Rights Issue including but not limited to the issue size rights entitlement ratio issue price record date rights issue schedule appointment of intermediaries draft Letter of Offer and such other matters incidental or connected therewith.5. Discussion on Appointment and Resignation of Directors.
वैल्यू रिसर्च से पूछें 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
